Price & volume screen · refreshed after the Sep 28, 2026 close
Six-month momentum leaders: Healthcare
Large companies with the strongest six-month price performance. Ranks companies worth at least $1B by their six-month split-adjusted return.
| # | Company | Price | 1M | 6M | From high | Mkt cap |
|---|---|---|---|---|---|---|
| 251 | ENOVEnovisHealthcare | $18.16 | −26.9% | −16.8% | −44.8% | $1.05B |
| 252 | BFAMBRIGHT HORIZONS FAMILY SOLUTIONSHealthcare | $63.73 | −14.3% | −18.3% | −41.7% | $3.10B |
| 253 | COOThe Cooper CompaniesHealthcare | $56.57 | −20.3% | −18.9% | −32.9% | $10.76B |
| 254 | INSMInsmedHealthcare | $117.67 | −3.1% | −19.0% | −44.3% | $25.70B |
| 255 | XRAYDENTSPLY SIRONAHealthcare | $9.28 | −15.9% | −19.1% | −36.8% | $1.85B |
| 256 | ALNYAlnylam PharmaceuticalsHealthcare | $255.36 | +7.9% | −19.5% | −48.0% | $34.17B |
| 257 | BKDBrookdale Senior LivingHealthcare | $11.04 | −8.7% | −20.1% | −34.2% | $2.64B |
| 258 | PBHPrestige Consumer HealthcareHealthcare | $46.93 | −8.4% | −20.8% | −33.2% | $2.22B |
| 259 | NAMSNewAmsterdam Pharma Company N.VHealthcare | $23.58 | −12.0% | −21.3% | −43.1% | $2.82B |
| 260 | TNDMTandem Diabetes CareHealthcare | $16.42 | −23.3% | −21.8% | −41.9% | $1.14B |
| 261 | STOKStoke TherapeuticsHealthcare | $25.50 | −21.8% | −22.4% | −33.5% | $1.65B |
| 262 | LMATLeMaitre VascularHealthcare | $82.34 | +3.4% | −22.8% | −29.9% | $1.88B |
| 263 | SNDXSyndax PharmaceuticalsHealthcare | $17.86 | −11.4% | −24.0% | −29.0% | $1.59B |
| 264 | CELCCelcuityHealthcare | $79.64 | −14.6% | −24.9% | −45.1% | $3.90B |
| 265 | VRDNViridian TherapeuticsHealthcare | $20.57 | −13.9% | −24.9% | −39.1% | $2.33B |
| 266 | RAREUltragenyx PharmaceuticalHealthcare | $14.41 | −45.1% | −25.6% | −60.6% | $1.42B |
| 267 | XENEXenon PharmaceuticalsHealthcare | $36.72 | −40.7% | −32.6% | −48.3% | $3.56B |
| 268 | PAHCPhibro Animal HealthHealthcare | $35.70 | −1.8% | −33.7% | −40.1% | $1.45B |
| 269 | AORTArtivionHealthcare | $22.95 | −13.9% | −35.0% | −51.8% | $1.12B |
| 270 | EYENational Vision HoldingsHealthcare | $16.12 | −9.8% | −35.9% | −45.3% | $1.27B |
| 271 | PODDInsuletHealthcare | $133.11 | −7.2% | −36.1% | −61.6% | $9.23B |
| 272 | BSXBoston ScientificHealthcare | $44.11 | −5.5% | −36.2% | −58.0% | $63.93B |
| 273 | IONSIonis PharmaceuticalsHealthcare | $45.57 | −27.0% | −36.8% | −47.3% | $7.57B |
| 274 | ZTSZOETISHealthcare | $71.43 | −4.8% | −37.0% | −51.6% | $29.52B |
| 275 | TYRATyra BiosciencesHealthcare | $21.45 | −17.9% | −40.9% | −45.8% | $1.47B |
Method & sources
Computed after each close from Massive / Polygon prices (split-adjusted), SEC filings, FINRA short-interest settlements and FMP earnings dates. Rows are rebuilt every session; a stock appears only when every criterion is met with current data. Full methodology
Informational screen, not a recommendation.